Obesity Drugs in 2026: Why the Focus Is Shifting to Long-Term Weight Management

Weight Loss Drug Market Could Reach $150 Billion Globally | Morgan Stanley The race to develop obesity drugs is entering a new phase. For several years, the biggest question was simple: How much weight can a drug help people lose? Now the focus is changing. Doctors and researchers are increasingly asking whether patients can maintain … Read more

Retatrutide for Weight Loss: What 2026 Research Shows About the Next-Generation Drug

Eli Lilly’s Retatrutide Hits Record Weight Loss, Challenges Surgery Efficacy | Whalesbook Retatrutide Is Producing Remarkable Weight-Loss Results The next generation of obesity medicines is moving quickly. One of the most closely watched candidates is retatrutide for weight loss, an experimental drug being developed by Eli Lilly. In May 2026, Lilly reported Phase 3 TRIUMPH-1 … Read more